Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |